Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy

Diabetes Care

Volumn 31, Issue 1, 2008, Pages 140-145

  Quattrini, Cristian ^a   Jeziorska, Maria ^a   Boulton, Andrew J M ^a   Malik, Rayaz A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR;

ADULT; ARTICLE; AUTONOMIC NERVE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE SEVERITY; ELECTROPHYSIOLOGY; EPIDERMIS CELL; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; MAJOR CLINICAL STUDY; MICROVASCULATURE; NERVE FIBER; NEUROLOGIC EXAMINATION; PROTEIN EXPRESSION; SENSORY ANALYSIS; SKIN BIOPSY; SKIN BLOOD FLOW; BIOPSY; BLOOD FLOW; CYTOLOGY; FOOT; INNERVATION; LASER DOPPLER FLOWMETRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SKIN; VASCULARIZATION;

BIOPSY; DIABETIC NEUROPATHIES; FOOT; HUMANS; LASER-DOPPLER FLOWMETRY; MIDDLE AGED; NERVE FIBERS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REGIONAL BLOOD FLOW; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38149042748     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1556     Document Type: Article

References (30)

1. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
2. Hobson MI, Green CJ, Terenghi G: VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat 197 (Pt. 4):591-605, 2000
3. Chattopadhyay M, Krisky D, Wolfe D, Glorioso JC, Mata M, Fink DJ: HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther 12:1377-1384, 2005
4. Price SA, Dent C, Duran-Jimenez B, Liang Y, Zhang L, Rebar EJ, Case CC, Gregory PD, Martin TJ, Spratt SK, Tomlinson DR: Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy. Diabetes 55:1847-1854, 2006
5. Kipnes MS, Ando DG, Cornblath DR: Single treatment, phase 1b placebo controlled trial of a zinc finger growth factor (ZFP) activator (SB-509) of a vascular endothelial growth factor (VEGF) in subjects with diabetic neuropathy (DN) (Abstract 1989-PO). Presented at the 66 annual meeting of the American Diabetes Association, 2006
6. Chavez JC, Almhanna K, Berti-Mattera LN: Transient expression of hypoxia-inducible factor-1 and target genes in peripheral nerves from diabetic rats. Neurosci Lett 374:179-182, 2005
7. Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC: The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127:1606-1615, 2004
8. Shun CT, Chang YC, Wu HP, Hsieh SC, Lin WM, Lin YH, Tai TY, Hsieh ST: Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 127:1593-1605, 2004
9. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, Hamwi J, Pollari D, Bixby B, Howard J, Singleton JR: Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29:1294-1299, 2006
10. Meijer JW, Smit AJ, Sonderen EV, Groothoff JW, Eisma WH, Links TP: Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med 19:962-965, 2002
11. Melzack R: The short-form McGill Pain Questionnaire. Pain 30:191-197, 1987
12. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJ: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19:377-384, 2002
13. Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O'Brien PC, Service FJ: Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 10:432-440, 1987
14. Dyck PJ, Zimmerman IR, Johnson DM, Gillen D, Hokanson JL, Karnes JL, Gruener G, O'Brien PC: A standard test of heat-pain responses using CASE IV. J Neurol Sci 136:54-63, 1996
15. Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 46:873-880, 1996
16. Goedkoop AY, de Rie MA, Teunissen MB, Picavet DI, van der Hall PO, Bos JD, Tak PP, Kraan MC: Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis. Arch Dermatol Res 297:51-59, 2005
17. Polydefkis M, Hauer P, Griffin JW, McArthur JC: Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 3:23-28, 2001
18. Cameron NE, Eaton SE, Cotter MA, Tesfaye S: Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973-1988, 2001
19. Polydefkis M, Griffin JW, McArthur J: New insights into diabetic polyneuropathy. JAMA 290:1371-1376, 2003
20. Sondell M, Lundborg G, Kanje M: Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 19:5731-5740, 1999
21. Schratzberger P, Schratzberger G, Silver M, Curry C, Kearney M, Magner M, Alroy J, Adelman LS, Weinberg DH, Ropper AH, Isner JM: Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat Med 6:405-413, 2000
22. Weninger W, Uthman A, Pammer J, Pichler A, Ballaun C, Lang IM, Plettenberg A, Bankl HC, Sturzl M, Tschachler E: Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest 75:647-657, 1996
23. Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF: Keratinocytederived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 105:44-50, 1995
24. Emanueli C, Schratzberger P, Kirchmair R, Madeddu P: Paracrine control of vascularization and neurogenesis by neurotrophins. Br J Pharmacol 140:614-619, 2003
25. Giatromanolaki A, Harris AL: Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res 21:4317-4324, 2001
26. Graiani G, Emanueli C, Desortes E, Van Linthout S, Pinna A, Figueroa CD, Manni L, Madeddu P: Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia 47:1047-1054, 2004
27. Kennedy JM, Zochodne DW: Influence of experimental diabetes on the microcirculation of injured peripheral nerve: functional and morphological aspects. Diabetes 51:2233-2240, 2002
28. Quattrini C, Harris ND, Malik RA, Tesfaye S: Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care 30:655-659, 2007
29. Rayman G, Baker NR, Krishnan ST: Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care 26:2697-2698, 2003
30. Simovic D, Isner JM, Ropper AH, Pieczek A, Weinberg DH: Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch Neurol 58:761-768, 2001